Dag R Olsen
Overview
Explore the profile of Dag R Olsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arteaga-Marrero N, Mainou-Gomez J, Rygh C, Lutay N, Roehrich D, Reed R, et al.
Acta Radiol
. 2018 Sep;
60(6):788-797.
PMID: 30231620
Background: Longitudinal monitoring of potential radiotherapy treatment effects can be determined by dynamic contrast-enhanced ultrasound (DCE-US). Purpose: To assess functional parameters by means of DCE-US in a murine subcutaneous model...
2.
Arteaga-Marrero N, Rygh C, Mainou-Gomez J, Adamsen T, Lutay N, Reed R, et al.
J Transl Med
. 2016 Feb;
14:59.
PMID: 26911196
No abstract available.
3.
Arteaga-Marrero N, Rygh C, Mainou-Gomez J, Adamsen T, Lutay N, Reed R, et al.
J Transl Med
. 2015 Dec;
13:383.
PMID: 26682742
Background: This study aims to assess the effect of radiation treatment on the tumour vasculature and its downstream effects on hypoxia and choline metabolism using a multimodal approach in the...
4.
Roe K, Mikalsen L, van der Kogel A, Bussink J, Lyng H, Ree A, et al.
Radiat Oncol
. 2012 May;
7:75.
PMID: 22621752
Background: Radiotherapy (RT) and androgen-deprivation therapy (ADT) are standard treatments for advanced prostate cancer (PC). Tumor vascularization is recognized as an important physiological feature likely to impact on both RT...
5.
Hagtvet E, Roe K, Olsen D
Radiat Oncol
. 2011 Oct;
6:135.
PMID: 21981945
Background: Tumor vasculature frequently fails to supply sufficient levels of oxygen to tumor tissue resulting in radioresistant hypoxic tumors. To improve therapeutic outcome radiotherapy (RT) may be combined with cytotoxic...
6.
Roe K, Kakar M, Seierstad T, Ree A, Olsen D
Radiat Oncol
. 2011 Jun;
6:65.
PMID: 21651782
Background: In modern cancer medicine, morphological magnetic resonance imaging (MRI) is routinely used in diagnostics, treatment planning and assessment of therapeutic efficacy. During the past decade, functional imaging techniques like...
7.
Roe K, Aleksandersen T, Kristian A, Nilsen L, Seierstad T, Qu H, et al.
Acta Oncol
. 2010 Sep;
49(7):914-21.
PMID: 20831478
Background: Non-invasive visualization of tumor biological and molecular processes of importance to diagnosis and treatment response is likely to be critical in individualized cancer therapy. Since conventional static (18)F-FDG PET...
8.
Weber D, Johanson S, Peguret N, Cozzi L, Olsen D
Int J Radiat Oncol Biol Phys
. 2010 Aug;
81(2):490-7.
PMID: 20800383
Purpose: To assess the excess relative risk (ERR) of radiation-induced cancers (RIC) in female patients with Hodgkin lymphoma (HL) female patients treated with conformal (3DCRT), intensity modulated (IMRT), or volumetric...
9.
Dale E, Harsaker V, Kristoffersen D, Bruland O, Olsen D
Strahlenther Onkol
. 2010 Feb;
186(3):163-8.
PMID: 20165821
Purpose: To investigate the lung tissue response measured with computed tomography (CT) after radiotherapy (RT) combined with metoclopramide. Patients And Methods: Patients with non-small cell lung cancer (tumor stage IIIA...
10.
Roe K, Muren L, Rorvik J, Olsen D, Dahl O, Bakke A, et al.
Acta Oncol
. 2008 Jul;
47(7):1257-64.
PMID: 18618299
Purpose: To assess the role of image parameters derived from dynamic contrast enhanced magnetic resonance imaging (DCEMRI) in bladder cancer staging, and to investigate the potential use of such parameter...